Acquisition of Peloton Pharmaceuticals by Aurora Cannabis

In the context of its restructuring process under the Bankruptcy and Insolvency act, Peloton Pharmaceuticals Inc. (“Peloton”) sold its assets to Aurora Cannabis Inc., a publicly traded company listed on the TSX under the “ACB” symbol, one of Canada’s largest producer and distributor of medical marijuana in the restaurant industry, with a market cap exceeding $800M. The transaction was done through a proposal providing for a reorganization of Peloton’s share capital, allowing creditors to be paid in full and Directors to obtain compensation. Fasken acted for the majority shareholders and directors of Peloton. Fasken’s team was comprised of Luc Morin, Alain Riendeau and Nicolas Mancini.